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Abstract
The main peculiarity of aspirin-intolerant polypous rhinosinusitis pathogenesis is the presence of “genetic block” of constitutive
cyclooxygenase being the key enzyme of the arachidonic acid metabolism. It justifies the necessity of studying its metabolic
peculiarities.
The objective of the research was to determine the level of arachidonic acid as well as the state of lipid and protein
peroxidation processes in patients with aspirin-intolerant polypous rhinosinusitis.
Materials and methods. The levels of arachidonic acid, malondialdehyde and oxidative modification of serum proteins were
studied in 20 patients with aspirin-intolerant polypous rhinosinusitis and 7 healthy individuals.
Results. Significantly elevated levels of arachidonic levels were observed. The search for alternative metabolic pathways
stimulated lipid and protein peroxidation processes and led to the increase in the levels of malondialdehyde and oxidative
modification of serum proteins. The peculiarities of biochemical changes indicated pro-inflammatory orientation of lipid
metabolism.
Conclusions. The obtained data confirmed the hypothesis of “genetic block” of the arachidonic acid metabolism as the main
pathogenetic component of aspirin-intolerant polypous rhinosinusitis and allowed us to clearly interpret biochemical picture of
the disease.
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Problem statement and analysis of the
recent research
Over the past decade, particular importance has been given
to the problem of pathogenesis, diagnosis and treatment of
chronic polypous rhinosinusitis being one of the urgent prob-
lems of modern medicine, in both Ukraine and Europe [17].
There is a wide range of variants of clinical course and differ-
ent responses to traditional methods of treatment. All these
peculiarities are combined into one diagnosis of “polypous
rhinosinusitis”. It suggests the heterogeneity of a group of
patients with the aforementioned diagnosis and the need for a
detailed study of various clinical variants of nasal polyposis.
It has been clinically observed that aspirin-intolerant poly-
pous rhinosinusitis is one of the most clinically damaging
pathogenetic variants of respiratory damage which is charac-
terized by progressive relapsing course and less effectiveness
of conservative and surgical treatment [15].
From the perspective of current view on the etiopatho-
genesis, aspirin-intolerant polypous rhinosinusitis is associ-
ated with changes in the arachidonic acid metabolism and
belongs to a group of metabolic diseases (MD) [4, 19, 20].
The main peculiarity of pathogenesis is the presence of genet-
ically determined reduction in the activity of the key enzyme
of the metabolism of unsaturated fatty acids, arachidonic acid
in particular - constitutive cyclooxygenase (COX-1) [5, 12].
“Genetic block” develops resulting in the disruption of the
biochemical chain and, therefore, pathogenetic processes of
MD occur at the molecular level; however, it is the initial
link of the complex pathogenetic chain. The pathogenesis at
the cellular level means that the main pathological processes
typical for aspirin-intolerant polypous rhinosinusitis occur in
the cells, mucosal cells lining the respiratory tract in particular.
Any block is characterized by the fact that all products up to
the level of block are not involved in the exchange. As a result,
arachidonic acid (ARA) accumulates in the body [11]. The
body tends to metabolize an excessive amount of ARA and
searches for alternative ways. High serum levels of fatty acids
are known to activate NADPH oxidase through the activation
of protein kinase C, thereby activating free radical formation
[22]. Free-radical reactions are the initial stage of the genera-
tion of reactive oxygen species (ROS) [8]. ROS are involved
in the metabolic processes of the body related to lipid, pro-
tein and nucleic acid metabolism as well as in the synthesis
of prostaglandins, leukotrienes, thromboxanes. They initiate
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lipid peroxidation (LPO) which is characterized by the accu-
mulation of toxic byproducts of LPO, oxidative modification
and damage to protein molecules and DNA [3]. ROS are able
to abstract hydrogen atoms from a CH2- group of ARA and
convert them to free radical groups - CH*. Such fatty acid
radical easily absorbs a molecule of oxygen and is converted
to peroxy radical which initiates further development of a
chain reaction. The products of such reactions are conjugated
diene and triplets; they are rather unstable and break down
to form aldehydes. Significant amount of malondialdehyde
(MDA) is observed; its concentration in the tissues can serve
as the indicator of LPO intensity [13]. The byproducts of LPO
can impair protein synthesis. The aggression of free radicals
against proteins results in changes in their physicochemical
properties. Oxidative modification of proteins (OMP) affects
the indicators of the isoelectric point, thermal stability and
proteolytic ability resulting in impaired enzymatic activity.
Enzymes may lose their catalytically active groups as well.
Such mechanism may occur in secondary impairment of en-
zyme synthesis. It has been proven that under oxidative stress
as well as due to ROS, not lipids bur proteins of the plasma
membranes primarily undergo oxidation which results in their
depolymerization and cell lysis [8]. Under physiological con-
ditions, the intensity of alternative metabolic processes is low.
Under pathological conditions, the intensification of these pro-
cesses is one of the universal etiopathogenetic mechanisms of
MD [7].
Many researchers agree that pro-inflammatory reaction
in the nasal epithelium induced by free radical oxidation is
the main cause of polyp formation [16, 21, 23]. Nevertheless,
the role of these processes in the pathogenesis of polyposis in
patients with aspirin intolerance has not yet been fully under-
stood [14]. However, in order to implement treatment due to
the intervention in the pathogenesis it is necessary to interpret
biochemical phenotype of the disease, i.e. to detect disrupted
metabolic components and biochemical mechanisms which
trigger the pathological process. Certainly, purposefully inter-
vention in the pathogenesis of the disease may be performed
only on this basis.
The objective of the research was to determine the level
of arachidonic acid as well as the state of lipid and protein
peroxidation processes in patients with aspirin-intolerant poly-
pous rhinosinusitis.
1. Materials and methods
The study included 20 patients at the age of 24-57 years (the
average age was 45.7±0.85 years) with chronic polypous
rhinosinusitis associated with aspirin intolerance who were
treated in the ear, nose, and throat (ENT) department of Ivano-
Frankivsk Regional Clinical Hospital during 2014-1015. The
control group included 7 somatically healthy donors at the
age of 20-50 years (the average age was 42.4±1.16 years).
In patients, blood was collected in the morning (on an
empty stomach). Heparin solution was used as an anticoag-
ulant. The object of the study was quarantine fresh-frozen
plasma stored at -20 ◦C.
Serum levels of arachidonic acid (20:4 ω-6) were deter-
mined using capillary gas-liquid chromatography. The identifi-
cation of chromatographic peaks was performed using individ-
ual standard solutions of fatty acid methyl esters. Registering
and processing of chromatograms were performed using the
HP ChemStation software.
The study was carried out using 7890A gas chromatograph
(Agilent Technologies) of the Institute of Animal Biology,
National Academy of Agrarian Sciences of Ukraine.
The analysis of LPO products – MDA was made on the
basis of determining the concentration of TBA-active prod-
ucts through incubating the samples with the thiobarbituric
acid, extracting reaction products with butanol and detecting
coloured complex by spectrophotometry. The indicators of
MDA were studied according to the method proposed by V.P.
Gavrilov [2].
The analysis of LPO products – OMP was based on the
interaction between oxidized amino acid residues and 2,4-
dinitrophenylhydrazine with the formation of derivatives hav-
ing characteristic absorption spectra. Aldehyde and ketone
derivatives of a neutral character were registered at a wave-
length of 370 nm, aldehyde and ketone derivatives of the main
character were registered at a wavelength of 430 nm. The indi-
cators of OMP were studied according to the method proposed
by E.E. Dubinina et al. [9].
To assess the differences between groups one-factor dis-
persion analysis with subsequent use of the Tukey’s multiple
comparison test at a significance level of 0.05 was applied [6].
Statistical software IBM SPSS Statistics 22.0 was used.
Pairwise comparisons of means in studied groups were per-
formed. To perform a sufficiently large number of pairwise
comparisons without loss of the statistical power the Tukey
HSD criterion was used. Pairwise comparison was performed
at a significance level of p=0.05, i.e. when performing all
pairwise comparisons the probability of obtaining one or more
false-negative results was 0.05. Correspondingly, if p>0.05,
one could conclude that the groups were not statistically dif-
ferent by the studied parameter and if p<0.05 – they were
statistically different.
2. Results and Discussion
According to current views, the main peculiarity of aspirin-
intolerant polypous rhinosinusitis pathogenesis is the presence
of genetically determined defect of COX-1 being the key
enzyme of the arachidonic acid metabolism (Fig. 1) [12]. In
our previous works, the reduction in the expression of COX-1
in the mucosa of the nasal cavity and polyps has been proven
using the methods of immunohistochemistry [5].
Any block is characterized by the fact that all products up
to the level of block are not involved in the exchange and one
of the most important and earliest mechanisms of pathology
development is the accumulation of products which are not
involved in the metabolism, i.e. those being located above
“genetic block”. Reduced COX-1 expression expectedly leads
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Figure 1. Arachidonic acid metabolism.
to intense accumulation of ARA as it is the substrate of COX-1
(Fig. 1).
The results revealed that in patients with aspirin-intolerant
polypous rhinosinusitis serum levels of ARA increased sig-
nificantly to 16.99±0.17% compared to 4.69±0.27% under
normal conditions (Table 1).
Decreased function of constitutive COX-1 and the accu-
mulation of ARA result in the search for possible bypass
routes of the metabolism as well as stimulate its possible di-
rections. If ARA metabolism via the cyclooxygenase pathway
is disrupted, it is included in other metabolic processes, the
intensity of which, under normal conditions, is low. In particu-
lar, peroxidation or lipid peroxidation is activated (Fig. 1) [1].
Significant amount of MDA is observed; its serum concentra-
tion can serve as the indicator of LPO intensity. According
to our data, serum levels of MDA in healthy individuals were
2.77±0.26 nmol/ml; in people with aspirin-intolerant poly-
pous rhinosinusitis they increased to 4.1±0.15 nmol/ml (Table
1).
Free radicals affect not only lipids but also proteins (Fig.
1). All enzymes providing the metabolic and regulatory pro-
cesses are known to be proteins. The products of such re-
actions are OMP. In healthy individuals, serum levels of ox-
idative modified proteins (aldehyde and ketone derivatives)
were: OMP370 – 3.47±0.09 mmol/g of protein, OMP430 –
1.93±0.04 mmol/g of protein. Our results showed signifi-
cant increase in OMP concentration in blood plasma of pa-
tients with aspirin-intolerant polypous rhinosinusitis: OMP370
- to 4.93±0.16 mmol/g of protein, OMP430 – to 6.81±0.94
mmol/g of protein (Table 1). Thus, the results obtained when
treating patients with aspirin-intolerant polyposis showed a
sharp increase (by nearly 4 times) in serum levels of ARA.
Significantly elevated ARA levels lead to the activation of
free radical processes and significant increase in the level of
LPO and OMP products.
The aggression of free radicals against proteins results in
changes in their physicochemical properties. Enzymes may
lose their catalytically active groups as well, which results in
impaired enzymatic activity and metabolic disorders. Such
mechanism may occur in secondary impairment of enzyme
responsible for ARA metabolism synthesis (Fig. 1).
Modified proteins are not restored; they are destroyed
through proteolytic degradation. It should be considered that
the reduction in enzymatic activity is accompanied by an
increase in the level of OMP in the cell [10]. It contributes to
the slowing down of the apoptotic and proteolytic processes in
such cells. The slowing down of apoptotic death, eosinophils
in particular is known to be one of the key events in the
pathogenesis of eosinophilic nasal polyposis [18].
3. Conclusions
1. In patients with aspirin-intolerant polypous rhinosinusi-
tis serum levels of ARA increased to 16.99±0.17%
significantly exceeding normal values (4.69±0.27%).
2. The activation of alternative routes, free radical lipid
oxidation in particular resulted in the increase in MDA
level compared to the control group (4.1±0.15 nmol/ml
versus 2.77±0.26 nmol/ml).
3. The increase in LPO intensity resulted in the elevation
of OMP370 level to 4.93±0.16 mmol/g of protein versus
3.47±0.09 mmol/g of protein under normal conditions
and OMP430 level to 6.81±0.94 mmol/g of protein ver-
sus 1.93±0.04 mmol/g of protein under normal condi-
tions.
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Table 1. Levels of ARA and major metabolites of peroxidation.
Metabolism Control group Study group
Serum levels of ARA (%) 4.69±0.27 16.99±0.17*
MDA (nmol/ml) 2.77±0.26 4.1±0.15*
OMP370 (mmol/g of protein) 3.47±0.09 4.93±0.16*
OMP430 (mmol/g of protein) 1.93±0.04 6.81±0.94*
Note.
* – a statistically significant difference between groups (p<0.05).
4. The aforementioned changes confirmed the hypothesis
of “genetic block of COX-1” as the main pathogenetic
component of aspirin-intolerant polypous rhinosinusi-
tis.
4. Prospects for further research
The possibility of using the study of the concentration of ARA
and peroxidation products to control the effectiveness of ther-
apy when treating patients with aspirin-intolerant polypous
rhinosinusitis is promising.
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